Does ROMOSOZUMAB-AQQG Cause Gait inability? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Gait inability have been filed in association with ROMOSOZUMAB-AQQG. This represents 0.2% of all adverse event reports for ROMOSOZUMAB-AQQG.
23
Reports of Gait inability with ROMOSOZUMAB-AQQG
0.2%
of all ROMOSOZUMAB-AQQG reports
1
Deaths
9
Hospitalizations
How Dangerous Is Gait inability From ROMOSOZUMAB-AQQG?
Of the 23 reports, 1 (4.3%) resulted in death, 9 (39.1%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?
Fall (646)
Fracture (612)
Arthralgia (517)
Injection site pain (490)
Bone density abnormal (454)
Off label use (419)
Hospitalisation (381)
Headache (360)
Product storage error (348)
Death (263)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which ROMOSOZUMAB-AQQG Alternatives Have Lower Gait inability Risk?
ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT
ROMOSOZUMAB-AQQG vs ROPINIROLE
ROMOSOZUMAB-AQQG vs ROPIVACAINE
ROMOSOZUMAB-AQQG vs ROSIGLITAZONE
ROMOSOZUMAB-AQQG vs ROSUVASTATIN